PER 1.23% 8.0¢ percheron therapeutics limited

Chart, page-5839

  1. 764 Posts.
    lightbulb Created with Sketch. 266
    with how she spoke at the investor webinar I believe the current strategy is her orchestration and that it’s coming from a place of understanding how to fast track commercialization and even drug use. I’m sure she looked at the risk of P3 with limited funding and suggested otherwise, I do wish she was CEO/ CSO etc. and was more invoked in day to day operations
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.